Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 176 | 930 | 1,793 | 13 | 119 |
| TOTAL | $216 | $941 | $1,793 | $13 | $129 |
| Non-Current Assets | |||||
| PPE Net | 147 | 158 | 145 | N/A | 3 |
| Other Non-Current Assets | 12 | 12 | 16 | 12 | 0 |
| TOTAL | $158 | $170 | $161 | $12 | $3 |
| Total Assets | $374 | $1,111 | $1,954 | $25 | $132 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,606 | 1,673 | 1,521 | 1,891 | 1,762 |
| Accrued Expenses | 1,659 | 1,670 | 1,708 | 1,584 | 1,269 |
| Other current liabilities | 1,048 | 1,050 | 1,064 | 1,070 | 1,047 |
| TOTAL | $4,312 | $4,394 | $4,293 | $4,574 | $4,077 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -75 | 115 | -20 | 0 | 0 |
| TOTAL | $7 | $7 | $N/A | $N/A | $N/A |
| Total Liabilities | $4,319 | $4,401 | $4,293 | $4,574 | $4,077 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,374 | 14,374 | 14,274 | 14,274 | 14,274 |
| Common Shares | 601 | 601 | 601 | 601 | 601 |
| Retained earnings | -118,030 | -117,450 | N/A | -116,199 | -115,586 |
| Other shareholders' equity | -227 | -152 | -116,595 | -2,750 | 0 |
| TOTAL | $-3,945 | $-3,290 | $-2,339 | $-4,550 | $-3,945 |
| Total Liabilities And Equity | $374 | $1,111 | $1,954 | $25 | $132 |